Although the precise function of HSPC111 remains unclear from our studies, its over-expression is common in a number of cancer cell types, and its association with poor outcome in breast cancer cohorts warrants its further analysis as an effector of estrogen and Myc action in both normal and neoplastic growth. The gene discussed is MYC; the disease is breast carcinoma.